Biotech Leader Amgen Expands to Ohio, Investing $365 Million & Creating 400 Jobs
By Laura Cowan
Laura K. Cowan is a tech editor and journalist whose work has focused on promoting sustainability initiatives for automotive, green tech, and conscious living media outlets.
Leading biotechnology company Amgen announced recently that it plans to invest $365 million to build a new manufacturing facility in New Albany, Ohio, which is located near new insurtech/healthtech hub Columbus. This move will create 400 new jobs. The facility will feature Amgen’s advanced assembly and product packaging capabilities for medicines to be distributed in the U.S.
“Amgen is a global pioneer on the front lines of restoring health and providing therapies for those fighting serious illnesses such as cancer,” said Ohio Governor Mike DeWine. “Attracting a biotechnology leader to the Columbus Region was a collaborative effort between the Ohio Development Services Agency, JobsOhio and its partners, and we look forward to working with Amgen as it improves healthcare throughout the world with talent from Ohio.”
Construction of the 270,000-square-foot facility is expected to begin in the fall of this year. Amgen will be hiring technicians, engineers, quality assurance, quality control, administrative and management positions.
“We are proud of our track record of providing a reliable supply of high-quality medicines for patients around the world,” said Amgen Executive Vice President of Operations Esteban Santos. “We are adding this additional assembly and packaging plant to our global supply chain network to support the anticipated growth in demand for Amgen medicines. We plan to include some of our most advanced digital automation technologies in this new location as we partner with the thriving business community of the Columbus Region to further expand biotechnology regionally.”
Founded in 1980 in Thousand Oaks, California, Amgen now serves millions of patients around the world suffering from illnesses such as cancer and heart disease. Amgen’s revenue in 2020 exceeded $25 billion, and it is one of the 30 companies that comprise the Dow Jones Industrial Average. Amgen has nearly 25,000 employees worldwide, including more than 14,000 in the U.S.
The Amgen facility in New Albany will be built to exacting environmental standards, consistent with the company’s goal of achieving carbon neutrality by 2027. The facility also will support Amgen’s participation as a founding member of OneTen, a coalition of many of the world’s largest, best-known companies that aims collectively to hire one million Black Americans into well-paying jobs over the next ten years, with a specific focus on those without a four-year college degree.
“We are excited to welcome Amgen to New Albany. They are a tremendous fit, from their company values to the quality of their products, and we are glad they saw the benefit of New Albany’s robust infrastructure and speed to market capabilities,” said New Albany Mayor Sloan Spalding. “Today is big win for our Region with respect to what Amgen brings to all of Ohio for manufacturing, research and development, education and workforce opportunities.”
From groundbreaking innovation to high-tech manufacturing, the Columbus Region is home to one of the most dynamic life science industries in the country. Companies spanning the life science industry have operations focused on R&D, technology and manufacturing. Amgen’s investment is the latest in a series of biopharma announcements in the Region over the past 12 months. From Sarepta’s new Gene Therapy Center of Excellence to Battelle’s launch of AmplifyBio, NCH’s launch of Andelyn Biosciences and Forge Biologic’s $130 million series B, the Columbus Region is on the cutting-edge of innovation in the life sciences industry. New Albany is located in Franklin County, which is home to an estimated 1,316,756 residents.